Showing results (1-10 of 455) with videos related to
Sort By:
Pageof 46
Annual Review of Medicine|January 1, 1992
Medical treatment of inflammatory bowel diseaseF Shanahan, S TarganDigestive Diseases and Sciences|March 1, 1988
Neuroendocrine modulation of the immune system. Possible implications for inflammatory bowel diseaseF Shanahan, P AntonGastroenterology|April 1, 1988
Human mucosal T-cell cytotoxicityF Shanahan, R Deem, R Nayersina, et al.Cellular Immunology|June 1, 1987
Modulation of ongoing human immunoglobulin synthesis by natural killer cellsH Kimata, F Shanahan, M Brogan, et al.The Journal of Allergy and Clinical Immunology|August 1, 1990
A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel diseaseA Saxon, F Shanahan, C Landers, et al.Journal of Clinical Immunology|January 1, 1989
Enhanced peripheral blood T-cell cytotoxicity in inflammatory bowel diseaseF Shanahan, B Leman, R Deem, et al.Immunopharmacology|November 1, 1990
Sulfasalazine inhibits the binding of TNF alpha to its receptorF Shanahan, A Niederlehner, N Carramanzana, et al.Immunopharmacology|April 1, 1986
Inhibition of cytotoxicity by sulfasalazine. II. Sulfasalazine and sulfapyridine inhibit different stages of the NK and NKCF lytic processesF Shanahan, A Niederlehner, R P MacDermott, et al.The American Journal of Medicine|December 1, 1988
Hermansky-Pudlak syndrome: an immunologic assessment of 15 casesF Shanahan, L Randolph, R King, et al.Pageof 46